Hiromitsu Maehira

895 total citations
83 papers, 522 citations indexed

About

Hiromitsu Maehira is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiromitsu Maehira has authored 83 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 41 papers in Oncology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiromitsu Maehira's work include Pancreatic and Hepatic Oncology Research (32 papers), Gallbladder and Bile Duct Disorders (14 papers) and Esophageal and GI Pathology (10 papers). Hiromitsu Maehira is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Gallbladder and Bile Duct Disorders (14 papers) and Esophageal and GI Pathology (10 papers). Hiromitsu Maehira collaborates with scholars based in Japan, United States and Belgium. Hiromitsu Maehira's co-authors include Hiroya Iida, Masaji Tani, Haruki Mori, Toru Miyake, Takeo Nomi, Shoji Kubo, Masaki Kaibori, Shogo Tanaka, Takuya Nakai and Masaki Ueno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and British journal of surgery.

In The Last Decade

Hiromitsu Maehira

64 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromitsu Maehira Japan 13 275 244 160 102 79 83 522
Tatsuma Sakaguchi Japan 13 204 0.7× 251 1.0× 176 1.1× 81 0.8× 86 1.1× 75 529
Zeljka Jutric United States 13 373 1.4× 331 1.4× 197 1.2× 96 0.9× 40 0.5× 40 559
Simone Famularo Italy 13 143 0.5× 182 0.7× 81 0.5× 94 0.9× 197 2.5× 52 408
Oleg Mironov Canada 12 104 0.4× 214 0.9× 119 0.7× 49 0.5× 65 0.8× 30 485
Mazin Hamed United Kingdom 11 161 0.6× 525 2.2× 91 0.6× 64 0.6× 207 2.6× 18 687
Maria Di Vita Italy 16 210 0.8× 401 1.6× 201 1.3× 48 0.5× 34 0.4× 48 667
Akira Umemura Japan 11 120 0.4× 410 1.7× 195 1.2× 186 1.8× 194 2.5× 83 618
Mark E. Brooke‐Smith Australia 12 424 1.5× 593 2.4× 199 1.2× 143 1.4× 138 1.7× 20 773
Eva Kalkum Germany 13 374 1.4× 338 1.4× 251 1.6× 72 0.7× 37 0.5× 35 605
Nobuyuki Sakurazawa Japan 15 545 2.0× 490 2.0× 202 1.3× 45 0.4× 19 0.2× 34 791

Countries citing papers authored by Hiromitsu Maehira

Since Specialization
Citations

This map shows the geographic impact of Hiromitsu Maehira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Maehira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Maehira more than expected).

Fields of papers citing papers by Hiromitsu Maehira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Maehira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Maehira. The network helps show where Hiromitsu Maehira may publish in the future.

Co-authorship network of co-authors of Hiromitsu Maehira

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromitsu Maehira. A scholar is included among the top collaborators of Hiromitsu Maehira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromitsu Maehira. Hiromitsu Maehira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Haruki, Hiromitsu Maehira, Shigeru Fujimoto, et al.. (2025). Durable disease control in unresectable hepatocellular carcinoma with atezolizumab plus half-dose bevacizumab: pathological complete response of peritoneal metastasis. Clinical Journal of Gastroenterology. 19(1). 291–297.
2.
Mori, Haruki, Hiromitsu Maehira, Hajime Ishikawa, et al.. (2025). Conversion surgery following severe cytokine release syndrome induced by immune checkpoint inhibitors doublet in advanced hepatocellular carcinoma. Clinical Journal of Gastroenterology. 18(4). 739–745.
3.
Mori, H., Hiromitsu Maehira, Hajime Ishikawa, et al.. (2025). Procalcitonin as an Early Predictive Marker for Infectious Complications after Hepatectomy. Digestive Surgery. 42(1). 17–25.
5.
Kojima, M., Toru Miyake, Sachiko Kaida, et al.. (2024). Perineoplasty for anal incontinence after obstetric anal sphincter injury repair: a case report. Surgical Case Reports. 10(1). 116–116. 1 indexed citations
6.
Maehira, Hiromitsu, Haruki Mori, Hiroki Ishikawa, et al.. (2024). Risk factors of early recurrence after radical resection for pancreatic cancer. HPB. 26. S342–S342. 1 indexed citations
8.
Takebayashi, Katsushi, Satoshi Murata, Sachiko Kaida, et al.. (2022). Adverse impact of postoperative intra-abdominal infectious complications on cancer recurrence-related survival after curative gastric cancer surgery. The American Journal of Surgery. 224(3). 949–954. 2 indexed citations
9.
Iida, Hiroya, Hiromitsu Maehira, H. Mori, et al.. (2022). Effect of the Gastrojejunostomy Position on the Postoperative Amount of Oral Intake in Pancreaticoduodenectomy. European Surgical Research. 64(2). 211–219.
10.
Maehira, Hiromitsu, Hiroya Iida, Haruki Mori, et al.. (2022). Impact of Preoperative Muscle Mass Maintenance and Perioperative Muscle Mass Loss Prevention After Pancreatectomy. Pancreas. 51(9). 1179–1185. 1 indexed citations
12.
Kojima, M., Toru Miyake, Tomoyuki Ueki, et al.. (2021). INI1-negative colorectal undifferentiated carcinoma with rhabdoid features and postoperative rapidly growing liver metastases: a case report and review of the literature. SHILAP Revista de lepidopterología. 7(1). 104–104. 5 indexed citations
13.
Matsunaga, Takashi, Tsuyoshi Yamaguchi, Sachiko Kaida, et al.. (2019). [Study of Eight Cases of Retroperitoneal Liposarcoma].. PubMed. 46(13). 2104–2106. 1 indexed citations
14.
Maehira, Hiromitsu, Toru Miyake, Hiroya Iida, et al.. (2019). Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Annals of Surgical Oncology. 26(13). 4791–4804. 25 indexed citations
15.
Maehira, Hiromitsu, et al.. (2019). Optimizing Perioperative Antimicrobial Therapy for Acute Cholecystitis Using Bile Gram Stain Results. International Surgery. 104(7-8). 364–370. 1 indexed citations
16.
Okumura, Satoshi, Hiroshi Kawashima, Hiroshi Yasuda, et al.. (2018). [A Case of Metastatic Carcinoma of Anal Fistula].. PubMed. 45(1). 148–150.
17.
Maehira, Hiromitsu, et al.. (2017). Prediction of difficult laparoscopic cholecystectomy for acute cholecystitis. Journal of Surgical Research. 216. 143–148. 33 indexed citations
18.
Maehira, Hiromitsu, Teiichi Sugiura, Yukiyasu Okamura, et al.. (2013). A Case of Adenosquamous Carcinoma of the Extrahepatic Bile Duct with Portal Vein Tumor Thrombus. The Japanese Journal of Gastroenterological Surgery. 46(2). 98–105. 1 indexed citations
19.
Maehira, Hiromitsu, Tomoharu Shimizu, Eiji Mekata, et al.. (2012). Evaluation of clinical courses of patients with left obstructive colorectal cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 73(11). 2745–2751. 1 indexed citations
20.
Shiomi, Hisanori, et al.. (2011). TWO CASES OF A LYMPHOEPITHELIAL CYST OF THE PANCREAS WITH SEBACEOUS DIFFERENTIATION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(4). 1015–1021.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026